Skip to main content

Want a detailed portfolio tracker?

Prime Medicine (PRME) P/E (2022 - 2026)

Prime Medicine (PRME) P/E from Oct 20, 2022 to Jun 3, 2026. The TTM Prime Medicine (PRME) P/E is -2.62. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Prime Medicine (PRME)

YearP/EChange
2026-2.62-0.18%
2025-2.62+40.63%
2024-1.87-62.81%
2023-5.02+48.99%
2022-3.37N/A

Comparison Prime Medicine (PRME) P/E with competitors

Prime Medicine (PRME) P/E is -2.62.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.10-103.90%
ENLVEnlivex Therapeutics Ltd0.15-105.73%
FGENFibroGen Inc0.24-109.16%
TRAWTraws Pharma Inc0.47-118.05%
FBIOFortress Biotech Inc0.71-126.95%
CHRSCoherus Biosciences Inc0.98-137.34%
ORMPOramed Pharmaceuticals Inc1.47-156.25%
AGENAgenus Inc2.05-178.20%
VIVSVivoSim Labs Inc2.54-196.81%
INVAInnoviva Inc3.19-221.72%
CRMDCorMedix Inc3.65-239.18%
ABEOAbeona Therapeutics Inc4.20-260.53%
VXRTVaxart Inc4.26-262.69%
CVACCureVac N.V.4.45-269.72%
SRPTSarepta Therapeutics Inc4.62-276.54%
GLPGGalapagos NV4.86-285.49%
RIGLRigel Pharmaceuticals4.92-287.81%
ZVRAZevra Therapeutics Inc4.97-289.89%
ABUSArbutus Biopharma Corp5.69-317.37%
CGENCompugen Ltd7.38-381.89%
AUPHAurinia Pharmaceuticals Inc9.25-453.19%
ACADAcadia Pharmaceuticals Inc9.59-466.04%
OMEROmeros Corporation9.88-477.32%
PLXProtalix BioTherapeutics Inc9.91-478.30%
SPROSpero Therapeutics Inc10.73-509.82%
ADMAAdma Biologics Inc11.33-532.57%
SVASinovac Biotech Ltd11.44-536.59%
TBPHTheravance Biopharma Inc11.78-549.60%
HRMYHarmony Biosciences Holdings Inc12.18-565.01%
TGTXTG Therapeutics Inc13.18-603.15%
INCYIncyte Corp13.38-610.88%
SABSSAB Biotherapeutics Inc14.06-636.68%
XOMAXOMA Corp14.95-670.56%
REGNRegeneron Pharmaceuticals Inc14.98-671.90%
PBYIPuma Biotechnology Inc15.05-674.58%
EXELExelixis Inc15.79-703.00%
NAGENiagen Bioscience Inc16.35-724.38%
CPRXCatalyst Pharmaceuticals Inc17.34-762.17%
MDXGMimedx Group Inc17.38-763.34%
ARGXArgen X SE23.07-980.80%
HALOHalozyme Therapeutics Inc23.20-985.73%
XOMAOXOMA Corp25.34-1067.59%
VRTXVertex Pharmaceuticals Inc25.66-1079.46%
XOMAPXOMA Corp25.67-1080.01%
CTMXCytomX Therapeutics Inc25.70-1081.07%
ASNDAscendis Pharma A/S26.35-1106.12%
RPRXRoyalty Pharma plc - Class A27.50-1149.69%
SLNOSoleno Therapeutics Inc29.02-1207.72%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1252.43%
BMRNBiomarin Pharmaceutical Inc37.51-1531.92%
APLSApellis Pharmaceuticals Inc39.02-1589.71%
KRYSKrystal Biotech Inc39.70-1615.54%
GMABGenmab40.20-1634.85%
ONCBeiGene Ltd67.03-2658.89%
TECHBio-Techne Corp68.59-2718.76%
VCELVericel Corp80.63-3178.19%
PHARPharming Group N.V.87.74-3449.66%
ALNYAlnylam Pharmaceuticals Inc124.93-4869.60%
TLXTelix Pharmaceuticals Ltd139.89-5440.62%
CORTCorcept Therapeutics Inc158.39-6146.84%